The Role of Alternative Lengthening of Telomeres Mechanism in Cancer: Translational and Therapeutic Implications.

Recagni, Marta; Bidzinska, Joanna; Zaffaroni, Nadia; Folini, Marco

Recagni, Marta; Bidzinska, Joanna; Zaffaroni, Nadia; Folini, Marco.

Afiliación

Recagni M; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy.
Bidzinska J; 2nd Department of Radiology, Medical University of Gdansk, 80-214 Gdansk, Poland.
Zaffaroni N; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy.
Folini M; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy.

Cancers (Basel) ; 12(4)2020 Apr 11.

Article en En | MEDLINE | ID: mdl-32290440

Palabras clave

ALT; adaptive response; resistance mechanisms; telomerase; telomerase inhibitors; telomeres

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google